Angiotensin AT1-receptor inhibition exacerbates renal injury resulting from partial unilateral ureteral obstruction in the neonatal rat

American Journal of Physiology - Renal Physiology

Volumn 293, Issue 1, 2007, Pages

  Coleman, Christopher M ^a   Minor, Jordan J ^a   Burt, Laura E ^a   Thornhill, Barbara A ^a   Forbes, Michael S ^a   Chevalier, Robert L ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Apoptosis; Collagen; Hydronephrosis; Nephrogenesis; smooth muscle actin

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ALPHA SMOOTH MUSCLE ACTIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; COLLAGEN; LOSARTAN; RENIN; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; HYDRONEPHROSIS; KIDNEY; KIDNEY CELL; KIDNEY DEVELOPMENT; KIDNEY INJURY; MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; URETER OBSTRUCTION; AGING; ANIMAL; BODY WEIGHT; DRUG ANTAGONISM; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASE; METABOLISM; NEWBORN; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; UPREGULATION;

AGING; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BODY WEIGHT; COLLAGEN; FEMALE; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY DISEASES; LOSARTAN; MACROPHAGES; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 2; RENIN-ANGIOTENSIN SYSTEM; SODIUM; UP-REGULATION; URETERAL OBSTRUCTION;

EID: 34548029735     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00071.2007     Document Type: Article

References (53)

1. Aguilera G, Kapur S, Feuillan P, Sunar-Akbasak B, Bathia AJ. Developmental changes in angiotensin II receptor subtypes and AT1 receptor mRNA in rat kidney. Kidney Int 46: 973-979, 1994.
2. Beharrie A, Franc-Guimond J, Rodriguez MM, Au J, Zilleruelo G, Abitbol CL. A functional immature model of chronic partial ureteral obstruction. Kidney Int 65: 1155-1161, 2004.
3. Cao ZM, Kelly DJ, Cox A, Casley D, Forbes JM, Martinello P, Dean R, Gilbert RE, Cooper ME. Angiotensin type 2 receptor is expressed in the adult rat kidney and promotes cellular proliferation and apoptosis. Kidney Int 58: 2437-2451, 2000.
4. Chen CO, Park MH, Forbes MS, Thornhill BA, Kiley SC, Yoo KH, Chevalier RL. Angiotensin converting enzyme inhibition aggravates renal interstitial injury resulting from partial unilateral ureteral obstruction in the neonatal rat. Am J Physiol Renal Physiol 292: F946-F955, 2007.
5. Chevalier RL. Obstructive nephropathy and the developing kidney: too little or too much angiotensin? Kidney Int 65: 1517-1518, 2004.
6. Chevalier RL, Cachat F. Role of angiotensin II in chronic ureteral obstruction. In: The Renin-Angiotensin System and Progression of Renal Diseases, edited by Wolf G. Basel: Karger, 2001, p. 250-260.
7. Chevalier RL, Thornhill BA, Belmonte DC, Baertschi AJ. Endogenous angiotensin II inhibits natriuresis following acute volume expansion in the neonatal rat. Am J Physiol Regul Integr Comp Physiol 270: R393-R397, 1996.
8. Chevalier RL, Thornhill BA, Wolstenholme JT. Renal cellular response to ureteral obstruction: role of maturation and angiotensin II. Am J Physiol Renal Physiol 277: F41-F47, 1999.
9. Chevalier RL, Thornhill BA, Wolstenholme JT, Kim A. Unilateral ureteral obstruction in early development alters renal growth: dependence on the duration of obstruction. J Urol 161: 309-313, 1999.
10. Chou SY, Cai H, Pai D, Mansour M, Huynh P. Regional expression of cyclooxygenase isoforms in the rat kidney in complete unilateral ureteral obstruction. J Urol 170: 1403-1408, 2003.
11. Chung KH, Chevalier RL. Arrested development of the neonatal kidney following chronic ureteral obstruction. J Urol 155: 1139-1144, 1996.
12. Daikha-Dahmane F, Levy-Beff E, Jugie M, Lenclen R. Foetal kidney maldevelopment in maternal use of angiotensin II type I receptor antagonists. Pediatr Nephrol 21: 729-732, 2006.
13. Desmouliere A, Darby IA, Gabbiani G. Normal and pathologic soft tissue remodeling: role of the myofibroblast, with special emphasis on liver and kidney fibrosis. Lab Invest 83: 1689-1707, 2003.
14. Dolber PC, Spach MS. Conventional and confocal fluorescence microscopy of collagen fibers in the heart. J Histochem Cytochem 41: 465-469, 1993.
15. Eikmans M, Baelde JJ, De Heer E, Bruijn JA. ECM homeostasis in renal diseases: a genomic approach. J Pathol 200: 526-536, 2003.
16. 2 receptors and NF-kappaB pathway, regulates the inflammatory response in unilateral ureteral obstruction. J Am Soc Nephol 15: 1514-1529, 2004.
17. Fern RJ, Yesko CM, Thornhill BA, Kim HS, Smithies O, Chevalier RL. Reduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in mice. J Clin Invest 103: 39-46, 1999.
18. Fujinaka H, Miyazaki Y, Matsusaka T, Yoshida H, Fogo AB, Inagami T, Ichikawa I. Salutary role for angiotensin in partial urinary tract obstruction. Kidney Int 58: 2018-2027, 2000.
19. Guron G, Friberg P. An intact renin-angiotensin system is a prerequisite for normal renal development. J Hypertens 18: 123-137, 2000.
20. Guron G, Marcussen N, Nilsson A, Sundelin B, Friberg P. Postnatal time frame for renal vulnerability to enalapril in rats. J Am Soc Nephol 10: 1550-1560, 1999.
21. Hashimoto N, Maeshima Y, Satoh M, Odawara M, Sugiyama H, Kashihara N, Matsubara H, Yamasaki Y, Makino H. Overexpression of angiotensin type 2 receptor ameliorates glomerular injury in a mouse remnant kidney model. Am J Physiol Renal Physiol 286: F516-F525, 2004.
22. Ishidoya S, Morrissey J, McCracken R, Reyes A, Klahr S. Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction. Kidney Int 47: 1285-1294, 1995.
23. Jensen AM, Li C, Praetorius HA, Norregaard R, Frische S, Knepper MA, Nielsen S, Frokiaer J. Angiotensin II mediates downregulation of aquaporin water channels and key renal sodium transporters in response to urinary tract obstruction. Am J Physiol Renal Physiol 291: F1021-F1032, 2006.
24. Kaneto H, Morrissey J, Klahr S. Increased expression of TGF-beta 1 mRNA in the obstructed kidney of rats with unilateral ureteral ligation. Kidney Int 44: 313-321, 1993.
25. Kaneto H, Morrissey J, McCracken R, Reyes A, Klahr S. Enalapril reduces collagen type IV synthesis and expansion of the interstitium in the obstructed rat kidney. Kidney Int 45: 1637-1647, 1994.
26. Lange-Sperandio B, Cachat F, Thornhill BA, Chevalier RL. Selectins mediate macrophage infiltration in obstructive nephropathy in newborn mice. Kidney Int 61: 516-524, 2002.
27. Lange-Sperandio B, Fulda S, Vandewalle A, Chevalier RL. Macrophages induce apoptosis in proximal tubule cells. Pediatr Nephrol 18: 335-341, 2003.
28. Lasaitiene D, Friberg P, Sundelin B, Chen Y. Neonatal RAS inhibition changes the phenotype of the developing thick ascending limb of Henle. Am J Physiol Renal Physiol 286: F1144-F1153, 2004.
29. Ma J, Nishimura H, Fogo A, Kon V, Inagami T, Ichikawa I. Accelerated fibrosis and collagen deposition develop in the renal interstitium of angiotensin type 2 receptor null mutant mice during ureteral obstruction. Kidney Int 53: 937-944, 1998.
30. Manucha W, Oliveros L, Carrizo L, Seltzer A, Valles P. Losartan modulation on NOS isoforms and COX-2 expressionin early renal fibrogenesis in unilateral obstruction. Kidney Int 65: 2091-2107, 2004.
31. Marxer-Meier A, Hegyi I, Loffing J, Kaissling B. Postnatal maturation of renal cortical peritubular fibroblasts in the rat. Anat Embryol (Berl) 197: 143-153, 1998.
32. McCausland JE, Bertram JF, Ryan GB, Alcorn D. Glomerular number and size following chronic angiotensin II blockade in the postnatal rat. Exp Nephrol 5: 201-209, 1997.
33. Miyajima A, Ito K, Asano T, Seta K, Ueda A, Hayakawa M. Does cyclooxygenase-2 inhibitor prevent renal tissue damage in unilateral ureteral obstruction? J Urol 166: 1124-1129, 2001.
34. Miyazaki Y, Tsuchida S, Nishimura H, Pope JC, Harris RC, McKanna JM, Inagami T, Hogan BM, Fogo A, Ichikawa I. Angiotensin induces the urinary peristaltic machinery during the perinatal period. J Clin Invest 102: 1489-1497, 1998.
35. Morrissey JJ, Klahr S. Enalapril decreases nuclear factor kappaB activation in the kidney with ureteral obstruction. Kidney Int 52: 926-933, 1997.
36. 2 receptor blockade on the pathogenesis of renal fibrosis. Am J Physiol Renal Physiol 276: F39-F45, 1999.
37. Nakatani T, Tamada S, Asai T, Iwai Y, Kim T, Tsujino T, Kumata N, Uchida J, Tashiro K, Kuwabara N, Komiya T, Sumi T, Okamura M, Miura K. Role of renin-angiotensin system and nuclear factor-kappaB in the obstructed kidney of rats with unilateral ureteral obstruction. Jpn J Pharmacol 90: 361-364, 2002.
38. Nishida M, Fujinaka H, Matsusaka T, Price J, Kon V, Fogo AB, Davidson JM, Linton MF, Fazio S, Homma T, Yoshida H, Ichikawa I. Absence of angiotensin II type 1 receptor in bone marrow-derived cells is detrimental in the evolution of renal fibrosis. J Clin Invest 110: 1859-1868, 2002.
39. Ozawa Y, Kobori H, Suzaki Y, Navar LG. Sustained renal interstitial macrophage infiltration following chronic angiotensin II infusions. Am J Physiol Renal Physiol 292: F330-F339, 2007.
40. Ozono R, Wang ZQ, Moore AF, Inagami T, Siragy HM, Carey RM. Expression of the subtype 2 angiotensin (AT2) receptor protein in rat kidney. Hypertension 30: 1238-1246, 1997.
41. Ruster C, Wolf G. Renin-angiotensin-aldosterone system and progression of renal disease. J Am Soc Nephol 17: 2985-2991, 2006.
42. Satoh M, Kashihara N, Yamasaki Y, Maruyama K, Okamoto K, Maeshima Y, Sugiyama H, Sugaya T, Murakami K, Makino H. Renal interstitial fibrosis is reduced in angiotensin II type 1a receptor-deficient mice. J Am Soc Nephol 12: 317-325, 2001.
43. Seikaly MG, Ho PL, Emmett L, Fine RN, Tejani A. Chronic renal insufficiency in children: the 2001 annual report of the NAPRTCS. Pediatr Nephrol 18: 796-804, 2003.
44. Shannan B, Seifert M, Leskov K, Willis J, Boothman D, Tilgen W, Reichrath J. Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer. Cell Death Differ 13: 12-19, 2006.
45. Shi YM, Li CL, Thomsen K, Jorgensen TM, Knepper MA, Nielsen S, Djurhuus JC, Frokiae J. Neonatal ureteral obstruction alters expression of renal sodium transporters and aquaporin water channels. Kidney Int 66: 203-215, 2004.
46. Siragy HM, Xue C, Abadir P, Carey RM. Angiotensin subtype-2 receptors inhibit renin biosynthesis and angiotensin II formation. Hypertension 45: 133-137, 2005.
47. Stoneking BJ, Hunley TE, Nishimura H, Ma J, Fogo A, Inagami T, Tamura M, Adams MC, Brock JW III, Kon V. Renal angiotensin converting enzyme promotes renal damage during ureteral obstruction. J Urol 160: 1070-1074, 1998.
48. Takese O, Cunnigham PN, Guo R, Hack BK, Quigg RJ. Clusterin induces apoptosis in proximal tubular epithelial cells exposed to LPS by preventing NF-kB-dependent Bcl-xL production (Abstract). J Am Soc Nephol 17: 781A, 2006.
49. Thornhill BA, Burt LA, Chen C, Forbes MS, Chevalier RL. Variable chronic partial ureteral obstruction in the neonatal rat: a new model of ureteropelvic junction obstruction. Kidney Int 67: 42-52, 2005.
50. Topcu SO, Pedersen M, Norregard R, Wang G, Knepper M, Djurhuus JC, Nielsen S, Jorgensen TM, Frokiaer J. Candesartan prevents long-term impairment of renal function in response to neonatal partial unilateral ureteral obstruction. Am J Physiol Renal Physiol 292: F736-F748, 2007.
51. Vanpee M, Blennow M, Linne T, Herin P, Aperia A. Renal function in very low birth weight infants: normal maturity reached during early childhood. J Pediatr 121: 784-788, 1992.
52. Yang J, Liu Y. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol 159: 1465-1475, 2001.
53. Yoo KH, Thornhill BA, Chevalier RL. Angiotensin stimulates TGF-beta 1 and clusterin in the hydronephrotic neonatal rat kidney. Am J Physiol Regul Integr Comp Physiol 278: R640-R645, 2000.